drugset / Trial / NCT07466160
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study was designed to evaluate the efficacy and safety of 7MW3711 in combination with JS207 in subjects with solid tumor.
Timeline
- Start
- 2026-02-11
- Primary completion
- 2027-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 7MW3711 | Other / unclassified | — | Intravenous |
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Cisplatin | Other / unclassified | — | Intravenous |
| Subject | JS207 | Monoclonal antibody | — | Intravenous |